C5 Convertase of the Alternative Pathway of Complement

This publication has 42 references indexed in Scilit:

• TRANSGENIC PIGS EXPRESSING HUMAN CD59 AND DECAY-ACCELERATING FACTOR PRODUCE AN INTRINSIC BARRIER TO COMPLEMENT-MEDIATED DAMAGE1
  Transplantation, 1997
• Complement Activation and Inhibition in Myocardial Ischemia and Reperfusion Injury
  Annual Review of Pharmacology and Toxicology, 1994
• Silica Induced Suppression of the Production of Third and Fifth Components of the Complement System by Human Lung CellsIn Vitro
  Immunopharmacology and Immunotoxicology, 1994
• Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis
  Science, 1990
• The effect of FUT-175 (nafamstat mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo
  International Journal of Immunopharmacology, 1990
• Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
  The Journal of Experimental Medicine, 1987
• Human Alveolar Macrophages Synthesize the Functional Alternative Pathway of Complement and Active C5 and C9 in Vitro
  Scandinavian Journal of Immunology, 1986
• Third component of human complement: purification from plasma and physicochemical characterization
  Biochemistry, 1976
• Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
  The Journal of Experimental Medicine, 1976
• THE ROLE OF PROPERDIN IN THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION
  The Journal of Experimental Medicine, 1974